Document ID: chunk:federal_register_of_legislation:F2025L00062:schedule:1:p21
Version: federal_register_of_legislation:F2025L00062
Segment Type: schedule
Provision Reference: sch 1 (pt 21/51)
Character Range: 60590–63754

instances): MP NP MW
(b) insert in the column headed "Circumstances" (all instances): C16261
[112] Schedule 1, Part 1, entries for Levothyroxine in the form Tablet containing 100 micrograms anhydrous levothyroxine sodium
(a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW
(b) insert in the column headed "Circumstances" (all instances): C16261
[113] Schedule 1, Part 1, entry for Levothyroxine in the form Tablet containing 125 micrograms anhydrous levothyroxine sodium
(a) omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW
(b) insert in the column headed "Circumstances": C16261
[114] Schedule 1, Part 1, entries for Levothyroxine in the form Tablet containing 200 micrograms anhydrous levothyroxine sodium
(a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW
(b) insert in the column headed "Circumstances" (all instances): C16261
[115] Schedule 1, Part 1, entry for Lidocaine in the form Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL
omit from the column headed "Section 100/ Prescriber Bag only": PB(MP) PB(NP) substitute: PB(MP) PB(NP) PB(MW)
[116] Schedule 1, Part 1, after entry for Maraviroc in the form Tablet 150 mg
insert:
Maraviroc  Tablet 150 mg  Oral  Maraviroc Waymade  IX  MP NP  C5008     120  5     60     D(100)

[117] Schedule 1, Part 1, after entry for Maraviroc in the form Tablet 300 mg
insert:
Maraviroc  Tablet 300 mg  Oral  Maraviroc Waymade  IX  MP NP  C5008     120  5     60     D(100)

[118] Schedule 1, Part 1, entry for Medroxyprogesterone in the form Injection containing medroxyprogesterone acetate 150 mg in 1 mL pre-filled syringe
omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW
[119] Schedule 1, Part 1, entries for Metformin
substitute:
Metformin  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  APO-Metformin XR 500                  TX  MP NP MW  C16261  P16261  120  5     120
Metformin  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  APO-Metformin XR 500                  TX  MP NP     C14238  P14238  240  5     120
Metformin  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  Diabex XR 500                         AL  MP NP MW  C16261  P16261  120  5     120
Metformin  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  Diabex XR 500                         AL  MP NP     C14238  P14238  240  5     120
Metformin  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  Diaformin Alphapharm XR               MQ  MP NP MW  C16261  P16261  120  5     120
Metformin  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  Diaformin Alphapharm XR               MQ  MP NP     C14238  P14238  240  5     120
Metformin  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  Metex XR                              RW  MP NP MW  C16261  P16261  120  5     120
Metformin  Tablet (extended release) containing metformin hydrochloride 500 mg  Oral  Metex